drugset / Trial / NCT06257693
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
The study is to assess whether the Enolen is safe and delivers anti-androgen medication locally in patients that are planning for radical prostatectomy.
Timeline
- Start
- 2024-06-21
- Primary completion
- 2028-06-30
- Completion
- 2028-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enzalutamide | Other / unclassified | — | Other |